In Silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control

Journal of Diabetes Science and Technology

Volumn 7, Issue 1, 2013, Pages 215-226

  Lee, Justin J ^a   Dassau, Eyal ^a   Zisser, Howard ^a   Harvey, Rebecca A ^a   Jovanovič, Lois ^a   Doyle III, Francis J ^a  

^a University of California

Author keywords

Artificial pancreas; Inhaled insulin; Model predictive control; Zone model predictive control

Indexed keywords

CARBOHYDRATE; INSULIN; TECHNOSPHERE INSULIN; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL PANCREAS; AUTOMATION; COMPUTER MODEL; DRUG ABSORPTION; EVALUATION STUDY; FAST FOOD; FEEDBACK SYSTEM; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; INHALER; INSULIN BLOOD LEVEL; INSULIN RELEASE; POSTPRANDIAL STATE; ALGORITHM; COMPUTER SIMULATION; DRUG DELIVERY SYSTEM; METHODOLOGY; TIME;

ALGORITHMS; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; INSULIN; PANCREAS, ARTIFICIAL; TIME FACTORS;

EID: 84883034718     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700127     Document Type: Article

References (41)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/diabetes/ pubs/pdf/ndfs-2011.pdf.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
3. Skyler JS. Atlas of diabetes. 3rd ed. Philadelphia: Current Medicine Group; 2005.
4. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90(4):450-9.
5. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care. 2004;27(8):1922-8. (Pubitemid 38989233)
6. Fogt EJ, Dodd LM, Jenning EM, Clemens AH. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system (Biostator). Clin Chem. 1978;24(8):1366-72. (Pubitemid 8392017)
7. Wang Y, Dassau E, Doyle FJ III. Closed-loop control of artificial pancreatic Beta-cell in type 1 diabetes mellitus using model predictive iterative learning control. IEEE Trans Biomed Eng. 2010;57(2):211-9.
8. Amrein K, Ellmerer M, Hovorka R, Kachel N, Parcz D, Korsatko S, Smolle K, Perl S, Bock G, Doll W, Kohler G, Pieber TR, Plank J. Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. Diabetes Technol Ther. 2010;12(5):405-12.
9. Zisser H, Dassau E, Bevier W, Harvey RA, Jovanovič L, Doyle FJ III. Clinical evaluation of a fully-automated artificial pancreas using zone-model predictive control with health monitoring system. American Diabetes Association 72nd Scientific Sessions, Jun 08-12, 2012, Philadelphia, PA.
10. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care. 2010;33(5):1072-6.
11. Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol. 2010;4(6):1374-81.
12. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010;375(9716):743-51.
13. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
14. Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Federici MO, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR. Closing the loop: the ADICOL experience. Diabetes Technol Ther. 2004;6(3):307-18. (Pubitemid 38821615)
15. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2009;3(5):1031-8.
16. Marchetti G, Barolo M, Jovanovič L, Zisser H, Seborg DE. An improved PID switching control strategy for type 1 diabetes. IEEE Trans Biomed Eng. 2008;55(3):857-65. (Pubitemid 351301242)
17. Parker RS, Doyle FJ III, Peppas NA. A model-based algorithm for blood glucose control in type 1 diabetic patients. IEEE Trans Biomed Eng. 1999;46(2);148-57. (Pubitemid 29058920)
18. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas. 2004;25(4):905-20. (Pubitemid 39121173)
19. Zisser H, Dassau E, Bevier W, Harvey RA, Percival M, Grosman B, Seborg DE, Jovanovič L, Doyle FJ III. Initial evaluation of a fully automated artificial pancreas. American Diabetes Association 71st Scientific Sessions, June 24-26, 2011, San Diego, CA.
20. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;2(27):27ra27.
21. Grosman B, Dassau E, Zisser H, Jovanovič L, Doyle FJ III. Multi-zone-MPC: a progressive control algorithm for the artificial pancreas. Proceedings of the International Federation of Automatic Control World Congress, August 28-September 2, 2011, Milano, Italy.
22. Van Heusden K, Dassau E, Zisser HC, Seborg DE, Doyle FJ III. Control-relevant models for glucose control using a priori patient characteristics. IEEE Trans Biomed Eng. 2012;59(7):1839-49.
23. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ III, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012;61(9):2230-7.
24. Elleri D, Allen JM, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with type 1 diabetes. Diabet Med. 2010;27(4):480-4.
25. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011;342;d1855.
26. Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, Simmons D, Dunger DB, Nodale M, Wilinska ME, Amiel SA, Hovorka R. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34(12):2527-9.
27. Patek SD, Magni L, Dassau E, Karvetski C, Tofanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle Iii FJ, Cobelli C, Kovatchev BP. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng. 2012;59(11):2986-99.
28. Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle FJ III, Patek SD, Avogaro A. Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care. 2012;35(9):e65-7.
29. Angelo R, Rousseau K, Grant M, Leone-Bay A, Richardson P. Technosphere insulin: defining the role of Technosphere particles at the cellular level. J Diabetes Sci Technol. 2009;3(3):545-54.
30. Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR. A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. Diabetes Care. 2002;25(11):2053-7. (Pubitemid 41071068)
31. Rave K, Potocka E, Heinemann L, Heise T, Boss AH, Marino M, Costello D, Chen R. Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. Diabetes Obes Metab. 2009;11(7):715-20.
32. Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ III. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol. 2010;4(4):961-75.
33. Ljung L. System identification theory for the user. 2nd ed. Upper Saddle River: Prentice Hall; 1999.
34. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81(2):442-8. (Pubitemid 18075238)
35. Harvey RA, Dassau E, Zisser H, Seborg DE, Jovanovič L, Doyle FJ III. Design of the health monitoring system for the artificial pancreas: low glucose prediction module. J Diabetes Sci Technol 2012;6(6):1345-54.
36. Harvey RA, Dassau E, Zisser H, Bevier W, Seborg DE, Jovanovič L, Doyle FJ III. Analysis of a hypoglycemia prediction algorithm on an extensive library of ambulatory data. American Diabetes Association 71st Scientific Sessions, June 24-26, 2011, San Diego, CA.
37. Dassau E, Jovanovic L, Doyle FJ III, Zisser HC. Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia - monitor, alert, and locate. J Diabetes Sci Technol. 2009;3(6):1501-6.
38. Manzone TA, Dam HQ, Soltis D, Sagar VV. Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study. J Nucl Med Technol. 2007;35(2):55-63. (Pubitemid 47549634)
39. Heinemann L, Ampudia-Blasco FJ. Glucose clamps with the Biostator: a critical reappraisal. Horm Metab Res. 1994;26(12):579-83. (Pubitemid 24381116)
40. Bequette BW. Glucose clamp algorithms and insulin time-action profiles. J Diabetes Sci Technol. 2009;3(5):1005-13.
41. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998;21(11):1870-5. (Pubitemid 28478285)